Back to Market Feed

Product Information

ACETAMINOPHEN 325 MG TABLET is a generic product labeled by McKesson, priced at $0.0262 per EA under NDC 63739008702. Its NADAC has been published 225 times since Dec 15, 2021.

ACETAMINOPHEN 325 MG TABLET

Acetaminophen 325mg
$0.0262per EA
Discontinued
OTC

Strength

325 mg/1

Manufacturer

McKesson

NDC

63739008702

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

3/18/2026

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

7/12/2021

Price Statistics

The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 225 times since Dec 15, 2021, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0262 per EA
All-time high$0.0267 (Nov 13, 2024)
All-time low$0.0208 (May 18, 2022)
52-week high$0.0267
52-week low$0.0247
Median price$0.0243
Average price$0.0243
Largest weekly change+21.2% (Jun 22, 2022)
Weeks tracked225
Tracking sinceDec 15, 2021

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-1.7%

1Y

+6.3%

3Y

+13.1%

5Y

N/A

All

+6.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Acetaminophen 325mg market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by McKesson, is $0.0262 per EA (NDC 63739008702), effective Apr 1, 2026.

How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?

Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 6.0%. It has been tracked across 225 weekly CMS publications since Dec 15, 2021.

What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?

Since Dec 15, 2021, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0208 (May 18, 2022) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0243 per EA.

Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ACETAMINOPHEN 325 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures ACETAMINOPHEN 325 MG TABLET?

ACETAMINOPHEN 325 MG TABLET (NDC 63739008702) is labeled by McKesson, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.